To determine whether TP53 is down‐regulated by increased histone methylation in vivo, we measured the enrichment of EZH2 and H3K27me3 levels across the TP53 promoter in 12 pairs of primary ESCC tissues (T) with matched adjacent tissues (L). Here, EZH2 is linked to esophageal squamous cell carcinoma.